2 out of 3 infants get RSV by age 1
That's why there's Beyfortus® (nirsevimab-alip) 50 mg and 100 mg injection
- Newborns and babies under 1 year of age born during or entering their first RSV season
- Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season
From Medals to Motherhood: Shawn Johnson East Shares Why She’s Championing Beyfortus
So, when she gave birth to her third baby, Barrett, known as Bear, Shawn and her husband decided after considering all the options to help protect him with Beyfortus at his first wellness visit.
Beyfortus is recommended by the American Academy of Pediatrics (AAP)
What is Beyfortus?
Beyfortus is not a vaccine. It's a preventative antibody that helps protect babies against serious RSV-related lung infections. While antibodies are naturally produced by our immune system to combat viruses, a baby's immune system may not be strong enough to generate antibodies to fight RSV. This is where preventative antibodies play a crucial role in providing additional protection. Beyfortus may not protect all children. Speak to your doctor about Beyfortus for your baby’s RSV protection.
Download The Discussion GuideRSV: a quick guide for parents
<1
It's unpredictable
RSV can go from cold-like symptoms to hospitalization in less than a week.
3-4
It's persistent
On average, babies hospitalized with RSV stay for 3-4 days in hospital.
It's serious
2/3
It's common
2 out of 3 babies will get RSV by age 1.
Help shield your baby from serious lung infections with Beyfortus
Is Beyfortus FDA approved?
Beyfortus has been added to the approved immunization schedule for babies and can be given at the same time as other routine childhood vaccines.
Sign up for personalized updates and reminders
As a new parent, learning about RSV can be overwhelming. Sign up today for personalized information and reminders to help protect your baby.
Frequently asked questions about Beyfortus
Beyfortus is an injection given directly to your baby that provides fast-acting antibody protection (immunization) against serious RSV lung infection. Beyfortus is recommended for newborns and babies born during or entering their first RSV season.
Vaccines are like self-defense instructors. They teach the immune system to create its own antibodies.
BeyfortusⓇ is a preventative antibody, which acts like a bodyguard. The RSV injection gives the protection that your baby’s maturing immune system can’t yet provide for itself.
As Beyfortus has been included in the approved immunization schedule, it can be given at the same time as other routine childhood vaccines. This means that it may be available at no cost for parents through private health insurance companies and the Vaccines for Children (VFC) program. VFC is a federally funded program that provides vaccines to children at no cost for those who might not be vaccinated because of an inability to pay. There may be an administration fee.
Explore Cost & Coverage
The development of Beyfortus took almost 7 years, with the first major clinical trial in babies in 2016. Clinical trials have included healthy babies born at term, premature babies, and babies with underlying health conditions.
Learn More About Beyfortus